These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15854652)

  • 1. Crystal structure and possible catalytic mechanism of microsomal prostaglandin E synthase type 2 (mPGES-2).
    Yamada T; Komoto J; Watanabe K; Ohmiya Y; Takusagawa F
    J Mol Biol; 2005 May; 348(5):1163-76. PubMed ID: 15854652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGH2 degradation pathway catalyzed by GSH-heme complex bound microsomal prostaglandin E2 synthase type 2: the first example of a dual-function enzyme.
    Yamada T; Takusagawa F
    Biochemistry; 2007 Jul; 46(28):8414-24. PubMed ID: 17585783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin F2alpha formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost.
    Komoto J; Yamada T; Watanabe K; Woodward DF; Takusagawa F
    Biochemistry; 2006 Feb; 45(7):1987-96. PubMed ID: 16475787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane prostaglandin E synthase-1: a novel therapeutic target.
    Samuelsson B; Morgenstern R; Jakobsson PJ
    Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of human prostaglandin F synthase (AKR1C3).
    Komoto J; Yamada T; Watanabe K; Takusagawa F
    Biochemistry; 2004 Mar; 43(8):2188-98. PubMed ID: 14979715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions.
    Xing L; Kurumbail RG; Frazier RB; Davies MS; Fujiwara H; Weinberg RA; Gierse JK; Caspers N; Carter JS; McDonald JJ; Moore WM; Vazquez ML
    J Comput Aided Mol Des; 2009 Jan; 23(1):13-24. PubMed ID: 18777160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of human microsomal prostaglandin E synthase-1 by computational modeling and site-directed mutagenesis.
    Huang X; Yan W; Gao D; Tong M; Tai HH; Zhan CG
    Bioorg Med Chem; 2006 May; 14(10):3553-62. PubMed ID: 16439136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic Asp-Arg interaction is essential for catalysis in microsomal prostaglandin E2 synthase.
    Brock JS; Hamberg M; Balagunaseelan N; Goodman M; Morgenstern R; Strandback E; Samuelsson B; Rinaldo-Matthis A; Haeggström JZ
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):972-7. PubMed ID: 26755582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
    Koeberle A; Werz O
    Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer.
    Rådmark O; Samuelsson B
    J Intern Med; 2010 Jul; 268(1):5-14. PubMed ID: 20497297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2.
    Ruan KH; Cervantes V; So SP
    Protein Eng Des Sel; 2009 Dec; 22(12):733-40. PubMed ID: 19850676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
    De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
    J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of a critical arginine in microsomal prostaglandin E synthase-1 shifts the isomerase activity to a reductase activity that converts prostaglandin H2 into prostaglandin F2alpha.
    Hammarberg T; Hamberg M; Wetterholm A; Hansson H; Samuelsson B; Haeggstro M JZ
    J Biol Chem; 2009 Jan; 284(1):301-305. PubMed ID: 18984580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
    Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding microscopic binding of human microsomal prostaglandin E synthase-1 (mPGES-1) trimer with substrate PGH2 and cofactor GSH: insights from computational alanine scanning and site-directed mutagenesis.
    Hamza A; Tong M; AbdulHameed MD; Liu J; Goren AC; Tai HH; Zhan CG
    J Phys Chem B; 2010 Apr; 114(16):5605-16. PubMed ID: 20369883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics.
    Luz JG; Antonysamy S; Kuklish SL; Condon B; Lee MR; Allison D; Yu XP; Chandrasekhar S; Backer R; Zhang A; Russell M; Chang SS; Harvey A; Sloan AV; Fisher MJ
    J Med Chem; 2015 Jun; 58(11):4727-37. PubMed ID: 25961169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
    Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
    J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
    Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
    Moon Y; Glasgow WC; Eling TE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.